Their expression has been evaluated in both sporadic adenomas and CRCs, with the identification of a marked reduction in the concentration of ERβ that could be already found in adenomas compared to controls, indicating its possible role in the early phases of carcinogenesis [58]. The gene discussed is ESR2; the disease is adenoma.